Brigham-Wyss Diagnostic Accelerator (IMAGE)
Caption
In a formalized process, Brigham clinicians identify unmet diagnostic needs that Wyss engineers will develop technology solutions and prototype assays for. These assays will be validated at the Brigham with patient samples under CLIA conditions, which align with the FDA's own evaluation and approval requirements, and the results provided back to Wyss engineers in an iterative process that informs the tests' optimization. Once the diagnostic assays meet all necessary requirements, their use in patient testing can be scaled.
Credit
Wyss Institute at Harvard University
Usage Restrictions
None
License
Licensed content